Print  |  Font Size Change Font Size
Search naabt.org  

The National Alliance of Advocates
for Buprenorphine Treatment

Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2

Newsletter Archives

Below is a collection of Buprenorphine Treatment-related newsletters published by the National Alliance of Advocates for Buprenorphine Treatment which contain the latest information about NAABT and its website, treatment studies, law changes and more.

2009

September
January / February

2008

November / December
August / September / October
April / May
January / February


2007

September - Special Edition
July, August, September
April, May, June
March
February
January


2006

December
October / November
September
July / August
June
 May
 April
 February
 January


2005

November / December

Newsletter Sign-Up

To receive our newsletter, enter your email address.
Email:  
National Drug & Alcohol Recovery MonthAddiction Survivors National Institute of HealthAlcohol AnswersNIDA
  1. U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
  2. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.